EMC Capital Management’s Verona Pharma VRNA Stock Holding History

EMC Capital Management’s Portfolio VRNA Stock Details VRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-2,500	Closed	-$267K	–	316
2025 Q3	$267K	Sell	2,500 -770	-24%	-$80.4K	0.13%	59
2025 Q2	$309K	Buy	3,270 +20	+0.6%	+$1.48K	0.17%	35
2025 Q1	$199K	Sell	3,250 -250	-7%	-$15K	0.12%	149
2024 Q4	$163K	Buy	3,500 +3,400	+3,400%	+$128K	0.09%	188
2024 Q3	$20K	Sell	100 -2,400	-96%	-$59.1K	0.01%	260
2024 Q2	$38K	Buy	+2,500	New	+$36.5K	0.02%	261

Other funds holding VRNA

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

EMC Capital Management's VRNA Position: Q4 2025 in Review

EMC Capital Management sold out of Verona Pharma (VRNA) in Q4 2025, closing a stake of 2,500 shares — an estimated $267K sold.

EMC Capital Management first reported a position in VRNA in Q2 2024 and held it in 6 quarters. The position peaked at $309K in Q2 2025. 1 fund tracked by Wall St. Rank holds VRNA as of Q4 2025.

EMC Capital Management reported no remaining Verona Pharma position as of Q4 2025 after selling out during the quarter.
EMC Capital Management sold 2,500 Verona Pharma shares in Q4 2025, an estimated $267K.
EMC Capital Management first reported a position in Verona Pharma in Q2 2024 and held it in 6 quarters.
EMC Capital Management's Verona Pharma position peaked at $309K in Q2 2025.
1 fund tracked by Wall St. Rank held Verona Pharma as of Q4 2025.

Based on EMC Capital Management's 13F filing for Q4 2025, filed 9 Mar 2026.